Success Metrics

Clinical Success Rate
97.7%

Based on 42 completed trials

Completion Rate
98%(42/43)
Active Trials
5(8%)
Results Posted
14%(6 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_2
15
24%
Ph phase_4
9
15%
Ph early_phase_1
2
3%
Ph phase_1
7
11%
Ph not_applicable
18
29%
Ph phase_3
10
16%

Phase Distribution

9

Early Stage

15

Mid Stage

19

Late Stage

Phase Distribution61 total trials
Early Phase 1First-in-human
2(3.3%)
Phase 1Safety & dosage
7(11.5%)
Phase 2Efficacy & side effects
15(24.6%)
Phase 3Large-scale testing
10(16.4%)
Phase 4Post-market surveillance
9(14.8%)
N/ANon-phased studies
18(29.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.4%

42 of 47 finished

Non-Completion Rate

10.6%

5 ended early

Currently Active

5

trials recruiting

Total Trials

62

all time

Status Distribution
Active(6)
Completed(42)
Terminated(5)
Other(9)

Detailed Status

Completed42
unknown8
Recruiting4
Withdrawn4
Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
62
Active
5
Success Rate
97.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.3%)
Phase 17 (11.5%)
Phase 215 (24.6%)
Phase 310 (16.4%)
Phase 49 (14.8%)
N/A18 (29.5%)

Trials by Status

unknown813%
suspended12%
terminated12%
not_yet_recruiting12%
active_not_recruiting12%
recruiting46%
completed4268%
withdrawn46%

Recent Activity

Clinical Trials (62)

Showing 20 of 62 trialsScroll for more
NCT07548541Not Applicable

Acute Effects of Creatine and L-Arginine Co-Supplementation on Anaerobic and Cognitive Performance in Recreationally Active Males

Completed
NCT04800692Phase 1

The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication

Active Not Recruiting
NCT05470998Phase 3

L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity

Completed
NCT07338682Phase 2

Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients

Recruiting
NCT07347509Not Applicable

Acute Effects of BCAA and L-Arginine on Performance in Elite Soccer Players

Completed
NCT06947265Phase 4

Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study

Completed
NCT03982160Phase 4

L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients

Recruiting
NCT06475391Not Applicable

The Effects of L-arginine Supplementation on Anaerobic Exercise Performance

Recruiting
NCT03679780Phase 1

The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction

Completed
NCT06405477Not Applicable

EFFECTS OF L-ARGININE SUPPLEMENTATION ON THE RECOVERY OF CARDIORESPIRATORY PARAMETERS AFTER SUBMAXIMAL EXERCISE TEST

Recruiting
NCT06405243Phase 3

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

Not Yet Recruiting
NCT05932979Phase 2

Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy.

Withdrawn
NCT02536170Phase 2

Arginine Therapy for Sickle Cell Disease Pain

Completed
NCT03665116Not Applicable

Effects of Dietary Supplement on Osteoarthritis

Unknown
NCT01413815Not Applicable

Effect of the Amino Acid L-arginine on Perioperative Cardio-vascular Risk in Non-selected Patients

Completed
NCT04054973Phase 2

L-arginine Study for Persistent Symptoms of Schizophrenia

Withdrawn
NCT02838030Phase 2

Efficacy of Aspirin and L-arginine in High Risk Preeclamptic

Suspended
NCT04535427Phase 2

Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis

Unknown
NCT01841281Phase 2

L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels

Completed
NCT03625596Not Applicable

Nutritional Supplements and Nitric Oxide Bioactivity

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
62